Beyond the fourth wave of genome-wide obesity association studies

Citations Over TimeTop 10% of 2012 papers

Abstract

Obesity and related complications are major health burdens. Almost 700 million adults are currently obese globally and the prevalence is predicted to rise towards 2030. The sudden change of lifestyle with physical inactivity and excessive calorie intake undoubtedly have a major part of the epidemic development; however, some individuals seem to be more prone to be affected by an unhealthy lifestyle than others. Hence, genetic predisposition also has an essential role in determining disease susceptibility and response to lifestyle factors. Since the introduction of genome-wide association studies (GWAS), the success of identifying obesity susceptibility variants have increased, and a total of 32 variants have been identified associating genome-wide significantly with body mass index (BMI) and 18 with measures of fat distribution during four overall obesity GWAS waves. However, the immediate success of the GWAS approach has eased off, but the proportion of explained variance for BMI by the identified obesity variants remains low. This review suggests and discusses new initiatives to take GWAS of obesity to the next level, including gene-environment interactions as modulating/masking factors, low-frequent or rare variants and ways to address such analyses, and finally reflections about the applicability of epigenetic modifications when elucidating the genetic background of obesity.

Related Papers

• → A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity(2007)4,441 cited
• → Obesity in Europe(1995)60 cited
• The Effects of Sobieum on Decrease of Body Mass Index (BMI) and Obesity Index of Obese Children(2009)
• → Diagnostic Accuracy of Body Mass Index (BMI) to Identify Obesity in Saudi Adult Population in a Community Based Setting(2017)
• → Determine The Risk Factors Of Central Obesity And Identify "Normal Body Mass Index Central Obesity" Among Myocardial Infarction Patients(2023)